STIOLTO RESPIMAT

Drug Boehringer Ingelheim Pharmaceuticals, Inc.
Total Payments
$4.9M
Transactions
184,156
Doctors
41,462
Companies
16

Payment Trends by Year

Year Amount Transactions Doctors
2024 $71,998 1,469 964
2023 $265,899 10,325 5,670
2022 $647,706 33,613 14,415
2021 $984,515 46,938 18,792
2020 $475,890 19,138 9,241
2019 $474,043 24,104 10,439
2018 $1.5M 48,141 18,153
2017 $496,695 428 37

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2.9M 181,560 59.9%
Consulting Fee $797,784 298 16.2%
Unspecified $505,136 387 10.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $424,041 165 8.6%
Travel and Lodging $227,699 139 4.6%
Education $14,634 1,607 0.3%

Payments by Type

General
$4.4M
183,769 transactions
Research
$505,136
387 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
LAMA/LABA vs ICS/LABA: 24 h PFT Boehringer Ingelheim Pharma GmbH & Co.KG $465,191 0
Exacerbations (1) Boehringer Ingelheim France S.A.S. $36,040 0
Exacerbations (1) Boehringer Ingelheim International GmbH $3,668 0
Long-term benefits of early intervention Boehringer Ingelheim International GmbH $236.33 0

Top Doctors Receiving Payments for STIOLTO RESPIMAT

Doctor Specialty Location Total Records
Unknown — Orlando, FL $537,427 409
, MD Pulmonary Disease San Antonio, TX $293,336 112
, M.D Internal Medicine Livonia, MI $71,987 39
, MD Internal Medicine Ann Arbor, MI $63,511 25
, M.D Pulmonary Disease Claremont, NH $55,340 38
, M.D Family Medicine Jenkintown, PA $49,374 24
, MD Diagnostic Radiology Philadelphia, PA $38,150 3
, MD Pulmonary Disease Winston Salem, NC $35,473 15
, M.D Internal Medicine Chapel Hill, NC $33,470 20
, MD Pulmonary Disease Boston, MA $32,073 9
, MD Critical Care Medicine Boston, MA $31,385 15
, MD Internal Medicine Buffalo, NY $28,206 19
Douglas Hogarth Pulmonary Disease Chicago, IL $25,093 9
, M.D Pulmonary Disease Torrance, CA $22,413 14
, MD Pulmonary Disease Philadelphia, PA $22,292 8
, M.D Internal Medicine Sacramento, CA $21,246 12
, MD Pulmonary Disease Birmingham, AL $18,285 8
, M.D Allergy & Immunology Chicago, IL $15,867 7
, MD Internal Medicine Boston, MA $15,350 4
, MD Family Medicine Coppell, TX $14,845 11
, DMD, MS Prosthodontics Waterville, ME $14,436 4
Frank Sciurba Specialist Pittsburgh, PA $14,425 4
, M.D Pulmonary Disease Boston, MA $14,350 4
, M.D Pulmonary Disease Baltimore, MD $13,981 7
, M.D Family Medicine Winnsboro, SC $13,683 2
123…1659»

Manufacturing Companies

Product Information

  • Type Drug
  • Total Payments $4.9M
  • Total Doctors 41,462
  • Transactions 184,156

About STIOLTO RESPIMAT

STIOLTO RESPIMAT is a drug associated with $4.9M in payments to 41,462 healthcare providers, recorded across 184,156 transactions in the CMS Open Payments database. The primary manufacturer is Boehringer Ingelheim Pharmaceuticals, Inc..

Payment data is available from 2017 to 2024. In 2024, $71,998 was paid across 1,469 transactions to 964 doctors.

The most common payment nature for STIOLTO RESPIMAT is "Food and Beverage" ($2.9M, 59.9% of total).

STIOLTO RESPIMAT is associated with 4 research studies, including "LAMA/LABA vs ICS/LABA: 24 h PFT" ($465,191).